AMSCO 400 Surgical Table from Steris plc - US hospitals lean on reliable flexibility
06.07.2026 - 04:25:26 | ad-hoc-news.de
By Daniel Foster, ad hoc news Bestsellers & Flagships Desk. Reviewed July 06, 2026, 2:25 AM ET. Details in the imprint.
The AMSCO 400 Surgical Table sits under a harsh white OR light, its steel base smudged where nurses have kicked the pedals during a long case. A scrub tech brushes past, tapping the feather-touch hand control to tilt the patient a few degrees. This is the daily workhorse Steris plc sells into US operating rooms.
What the AMSCO 400 offers
Steris positions the AMSCO 400 Surgical Table as a general-purpose operating table with a maximum patient weight capacity of 1,000 lb when the patient is centered on the tabletop. That high capacity is a practical selling point for US hospitals, which face rising rates of obesity and must safely manage heavier patients in the OR. The table offers a 22 in to 42 in adjustable height range, allowing surgeons and anesthesiologists to set up at an ergonomic working level whether they prefer to stand high or work closer to the floor.
According to Steris product materials, the AMSCO 400 provides longitudinal sliding of up to 9.5 in to improve imaging access, especially for C-arm fluoroscopy and intraoperative X-ray. The table supports Trendelenburg and reverse Trendelenburg positioning, as well as lateral tilt, so anesthesiology teams can quickly adjust patient orientation during complex procedures. A removable head section and a modular pediatric extension option broaden case coverage from standard adult general surgery to smaller pediatric patients, while radiolucent table sections help maintain imaging quality.
More on Steris plc and its OR portfolio
Explore how Steris plc builds recurring revenue with surgical tables, sterile processing, and infection-prevention solutions alongside the AMSCO 400 line.
Designed for busy US ORs
Standing next to the table during a mock case, you notice how the hand control buttons have a slight click and a backlit outline. That tactile feedback matters when circulator nurses, under pressure from the surgeon, need to reposition the patient without glancing away from the sterile field. Steris describes a "feather-touch" control surface designed to respond to light finger pressure. The base’s foot-end design gives anesthesia access to the airway and lines, while cables are routed so they do not easily snag shoes or carts.
In US ambulatory surgery centers, managers balance cost and durability across a fleet of OR tables. Steris highlights a stainless-steel column cover, sealed surfaces, and materials selected to handle repeated cleaning with hospital-grade disinfectants. Infection prevention protocols increasingly call for more frequent wipe-downs between cases, and OR equipment that pits or corrodes under harsh chemicals adds both cost and risk. By keeping critical moving parts protected and surfaces smooth, Steris aims to fit the AMSCO 400 into facilities that run tightly scheduled back-to-back surgeries.
Compatibility and accessories
The AMSCO 400 platform is built to work with a range of Steris accessories, including arm boards, leg holders, and headrests tailored to neurosurgery, ENT, and orthopedic cases. Facilities that already own legacy AMSCO tables often reuse compatible accessories, helping control capital budgets while upgrading the table itself. For hospitals adding hybrid ORs with more imaging, radiolucent extensions and carbon fiber sections can support vascular and spine procedures requiring intraoperative fluoroscopy. The table is also compatible with several Steris patient positioning systems aimed at bariatric and robotic surgery workflows.
From a practical standpoint, facility directors look at floor footprint, clearance for OR booms, and integration with room layouts. Steris publishes dimensional drawings for the AMSCO 400 so architects and planners can model clearances in design software. The table base is compact enough to fit into standard OR suites while still offering the stability required for high-weight patients and extreme positioning ranges. That balance between footprint and stability can be a deciding factor when hospitals standardize on a single table platform.
US availability and pricing signals
While Steris does not list public retail pricing for the AMSCO 400 Surgical Table, purchasing managers in US systems typically see OR tables in this general category priced in the tens of thousands of dollars per unit, depending on configuration, imaging options, and accessory bundles. Steris markets the AMSCO 400 directly to hospitals and ambulatory centers through its sales organization and capital equipment contracts. Because tables are capital purchases, they often flow through multi-year framework agreements or group purchasing organizations, spreading costs across departments.
US availability is straightforward: Steris operates a large healthcare portfolio focused on infection prevention, sterile processing, and surgical infrastructure across North America, and the AMSCO-branded tables form part of that installed base. In earnings calls and investor presentations, executives including CEO Dan Carestio have emphasized Steris’s recurring revenue streams from service, consumables, and equipment upgrades linked to OR infrastructure. While individual product sales numbers for the AMSCO 400 are not broken out publicly, surgical tables as a category sit within Steris’s healthcare segment, which accounts for a significant portion of revenue and adjusted operating income.
Why the AMSCO 400 matters for Steris plc stock
For US investors, the AMSCO 400 Surgical Table is another reminder that Steris plc is not just a sterilization or washer-disinfector name. It sells the physical platforms under patients in the OR, tying Steris into long-term equipment replacement cycles and service contracts. Surgical tables tend to have multi-year lifespans, but once a facility standardizes around a manufacturer, accessory purchases, service agreements, and bundled infrastructure upgrades follow. That supports a base of relatively predictable cash flows rather than one-off capital spikes.
Steris plc stock (NYSE: STE) continues to draw investor attention as a diversified healthcare equipment and services company with exposure to infection prevention, surgical infrastructure, and life sciences; the AMSCO 400 Surgical Table contributes to its installed base and recurring capital and service revenue, even though the company does not disclose table-specific sales figures.
Key facts on the AMSCO 400 Surgical Table
- Product: AMSCO 400 Surgical Table
- Manufacturer: Steris plc
- Category: Flagship OR equipment (surgical table)
- Launch: Marketed as part of the AMSCO OR infrastructure line; in active portfolio for multiple years
- MSRP / Price: Not publicly listed; typical OR tables in its class are ordered via capital contracts in the tens of thousands of USD per unit
- Availability: Sold to US hospitals and ambulatory surgery centers through Steris’s healthcare equipment sales network
- Target audience: Hospital OR directors, ambulatory surgery center managers, biomedical engineering teams, and surgeons seeking flexible general-purpose tables
- Standout / USP: High 1,000 lb centered weight capacity with ergonomic controls and imaging-friendly features tailored to busy US ORs
This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.
